Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001415889-25-016249

Director acquired 4,793 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Humphries William D. Director 2025-06-06 Option exercise +4,793 33,525 D
Derivatives
Humphries William D. Director 2025-06-05 Grant or award · Stock Option (Right to Buy) +42,350 42,350 D
Humphries William D. Director 2025-06-05 Grant or award · Restricted Stock Units +11,580 11,580 D
Humphries William D. Director 2025-06-06 Option exercise · Restricted Stock Units −4,793 0 D
Loading xslF345X05/form4-06092025_040606.xml…